P1182: A PROSPECTIVE STUDY OF TCR MEASURABLE RESIDUAL DISEASE IN PERIPHERAL T-CELL LYMPHOMA

• Austin Jacobsen,
• Ying Huang,
• Natalie Hill,
• Karina Elias,
• Matthew Holman,
• Skyler Gordon,
• Nicole Foley,
• David Russler-Germain,
• Marcus Watkins,
• Eric D. Jacobsen,
• Alison Moskowitz,
• Amanda Cashen,
• Todd A. Fehniger,
• Brad Kahl,
• Armin Ghobadi,
• Beth Reagan,
• Anne Fischer,
• Fei Wan,
• Steven Horwitz,
• Neha Mehta-Shah

Affiliations

Austin Jacobsen

1 Invivoscribe Inc., San Diego, United States

Ying Huang

1 Invivoscribe Inc., San Diego, United States

Natalie Hill

1 Invivoscribe Inc., San Diego, United States

Karina Elias

1 Invivoscribe Inc., San Diego, United States

Matthew Holman

1 Invivoscribe Inc., San Diego, United States

Skyler Gordon

1 Invivoscribe Inc., San Diego, United States

Nicole Foley

2 Washington University School of Medicine, Saint Louis, United States

David Russler-Germain

2 Washington University School of Medicine, Saint Louis, United States

Marcus Watkins

2 Washington University School of Medicine, Saint Louis, United States

Eric D. Jacobsen

3 Dana-Farber Cancer Institute, Boston, United States

Alison Moskowitz

4 Memorial Sloan Kettering Cancer Center, New York, United States

Amanda Cashen

2 Washington University School of Medicine, Saint Louis, United States

Todd A. Fehniger

2 Washington University School of Medicine, Saint Louis, United States

Brad Kahl

2 Washington University School of Medicine, Saint Louis, United States

Armin Ghobadi

2 Washington University School of Medicine, Saint Louis, United States

Beth Reagan

2 Washington University School of Medicine, Saint Louis, United States

Anne Fischer

2 Washington University School of Medicine, Saint Louis, United States

Fei Wan

2 Washington University School of Medicine, Saint Louis, United States

Steven Horwitz

4 Memorial Sloan Kettering Cancer Center, New York, United States

Neha Mehta-Shah

2 Washington University School of Medicine, Saint Louis, United States